Nothing Special   »   [go: up one dir, main page]

PE20080931A1 - Imidazopirazinas como inhibidores de proteina quinasa - Google Patents

Imidazopirazinas como inhibidores de proteina quinasa

Info

Publication number
PE20080931A1
PE20080931A1 PE2007001524A PE2007001524A PE20080931A1 PE 20080931 A1 PE20080931 A1 PE 20080931A1 PE 2007001524 A PE2007001524 A PE 2007001524A PE 2007001524 A PE2007001524 A PE 2007001524A PE 20080931 A1 PE20080931 A1 PE 20080931A1
Authority
PE
Peru
Prior art keywords
alkyl
compounds
imidazopyrazines
protein kinase
kinase inhibitors
Prior art date
Application number
PE2007001524A
Other languages
English (en)
Inventor
David B Belanger
M Arshad Siddiqui
Timothy J Guzi
Patrick J Curran
Praveen K Tadikonda
Blake Hamann
Panduranga Adulla P Reddy
Lianyun Zhao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39276164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080931(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20080931A1 publication Critical patent/PE20080931A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE IMIDAZO[1,2-a]PIRAZINA DE FORMULA (I) DONDE L ES S, S(O) O S(O2); G ES ALQUILO(C1-C20), ALQUENILO(C2-C15), CICLOALQUILO(C3-C10), ENTRE OTROS; R1 ES H, HALO, ALQUILO(C1-C20), ARILO(C6-C14), ENTRE OTROS; R2 ES H, ALQUILO(C1-C20), ARILO(C6-C14), ALQUENILO(C2-C15), ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON CF3, CN, OCF3, ENTRE OTROS SUSTITUYENTES; R3 ES H, ALQUILO(C1-C20), CICLOALQUILO(C3-C10), HETEROARILO DE 5 A 14 MIEMBROS, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON HALO, CF3, CN, OCF3, ENTRE OTROS SUSTITUYENTES. SON COMPUESTOS PREFERIDOS LOS COMPUESTOS DE FORMULA (i), (ii), ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE AURORA QUINASA SIENDO UTILES EN EL TRATAMIENTO DE CANCER, ARTRITIS, ENFERMEDAD DE ALZHEIMER
PE2007001524A 2006-11-08 2007-11-06 Imidazopirazinas como inhibidores de proteina quinasa PE20080931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85824406P 2006-11-08 2006-11-08

Publications (1)

Publication Number Publication Date
PE20080931A1 true PE20080931A1 (es) 2008-07-19

Family

ID=39276164

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001524A PE20080931A1 (es) 2006-11-08 2007-11-06 Imidazopirazinas como inhibidores de proteina quinasa

Country Status (11)

Country Link
US (1) US7511040B2 (es)
EP (1) EP2079746A2 (es)
JP (1) JP2010509328A (es)
CN (1) CN101589045A (es)
AR (1) AR063581A1 (es)
CA (1) CA2669465A1 (es)
CL (1) CL2007003212A1 (es)
MX (1) MX2009005011A (es)
PE (1) PE20080931A1 (es)
TW (1) TW200829588A (es)
WO (1) WO2008057512A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0716292D0 (en) 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
EP2313097B1 (en) * 2008-07-24 2013-03-27 Nerviano Medical Sciences S.r.l. Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents
CN102105147B (zh) * 2008-07-24 2013-07-03 内尔维阿诺医学科学有限公司 包含aurora激酶抑制剂和抗肿瘤药的治疗组合
JP5746032B2 (ja) * 2008-09-19 2015-07-08 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ ３，４−ジヒドロ−２Ｈ−ピロロ［１，２−ａ］ピラジン−１−オン誘導体
TW201107329A (en) * 2009-07-30 2011-03-01 Oncotherapy Science Inc Fused imidazole derivative having ttk inhibitory action
US8993535B2 (en) 2009-09-04 2015-03-31 Merck Sharp & Dohme Corp. Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
NZ599597A (en) 2009-10-30 2013-05-31 Janssen Pharmaceutica Nv IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
JP5841078B2 (ja) * 2010-03-18 2016-01-06 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ イミダゾピラジン
CN103038235B (zh) * 2010-06-01 2015-07-29 拜耳知识产权有限责任公司 取代的咪唑并吡嗪
AU2011261375B2 (en) 2010-06-04 2016-09-22 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
EP2651950A1 (en) 2010-12-17 2013-10-23 Bayer Intellectual Property GmbH 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
WO2012080236A1 (en) 2010-12-17 2012-06-21 Bayer Pharma Aktiengesellschaft 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
EP2651947B1 (en) 2010-12-17 2014-12-10 Bayer Intellectual Property GmbH 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
US8673905B2 (en) * 2011-03-17 2014-03-18 Hoffmann-La Roche Inc. Imidazo pyrazines
EP2723744B1 (en) 2011-06-27 2016-03-23 Janssen Pharmaceutica, N.V. 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
US9669035B2 (en) 2012-06-26 2017-06-06 Janssen Pharmaceutica Nv Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
MX362197B (es) 2012-07-09 2019-01-08 Janssen Pharmaceutica Nv Derivados de imidazo[1,2-b]piridazina e imidazo[1,2-a]pirazina como inhibidores de la fosfodiesterasa 10; y el uso de los mismos en el tratamiento de trastornos neurológicos, psiquiátricos y metabólicos.
JP6310144B2 (ja) * 2014-07-14 2018-04-18 ギリアード サイエンシーズ， インコーポレイテッド がんを処置するための組み合わせ
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
US10562902B2 (en) 2015-08-13 2020-02-18 Beijing Hanmi Pharmaceutical Co., Ltd. IRAK4 inhibitor and use thereof
CN107056789B (zh) * 2017-04-21 2019-03-29 陈剑 具有取代吡嗪并咪唑类衍生物,其制备及其在医药上的应用
US20230348475A1 (en) * 2020-09-17 2023-11-02 The Translational Genomics Research Institute Imidazopyridazine and imidazopyrazine compounds as inhibitors of cdk7

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2499756C (en) * 2002-09-23 2011-07-12 Schering Corporation Imidazopyrazines as cyclin dependent kinase inhibitors
US7186832B2 (en) * 2003-02-20 2007-03-06 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
WO2005085252A1 (en) * 2004-03-04 2005-09-15 Biofocus Discovery Limited Imidazo ‘1,2-a’ pyrazine compounds which interact with protein kinases
EP1812439B2 (en) * 2004-10-15 2017-12-06 Takeda Pharmaceutical Company Limited Kinase inhibitors
TW200803863A (en) * 2005-11-10 2008-01-16 Schering Corp Method for inhibiting protein kinases
TW200804386A (en) * 2005-11-10 2008-01-16 Schering Corp Imidazopyrazines as protein kinase inhibitors

Also Published As

Publication number Publication date
TW200829588A (en) 2008-07-16
CN101589045A (zh) 2009-11-25
WO2008057512A2 (en) 2008-05-15
MX2009005011A (es) 2009-05-20
AR063581A1 (es) 2009-02-04
EP2079746A2 (en) 2009-07-22
CL2007003212A1 (es) 2008-06-27
JP2010509328A (ja) 2010-03-25
CA2669465A1 (en) 2008-05-15
WO2008057512A3 (en) 2008-06-26
US7511040B2 (en) 2009-03-31
US20080139571A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
PE20080931A1 (es) Imidazopirazinas como inhibidores de proteina quinasa
PE20041000A1 (es) Pirazolopirimidinas como inhibidores de la quinasa dependientes de ciclina
PE20120505A1 (es) Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a
PE20070805A1 (es) Imidazopirazinas como inhibidores de proteinquinasa
EA200401194A1 (ru) Миметики глюкокортикоидов, способы их получения, фармацевтические композиции и их применение
PE20041076A1 (es) Nuevas pirazolopirimidinas como inhibidores de la quinasa dependientes de ciclina
PE20110387A1 (es) Aminotriazolo-piridinas como inhibidores de cinasa
PE20151249A1 (es) Derivados de pirazolopirimidina como inhibidores de jak quinasas
UY29414A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
PE20090964A1 (es) Derivados de pirrolo[2,3-d]pirimidina como inhibidores de proteina quinasa b
EA200901138A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
EA201100299A1 (ru) Органические соединения
PE20091211A1 (es) Derivados de pirazolopirimidina como moduladores de pde9a
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
PE20070531A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
PE20040999A1 (es) Nuevas pirazolopirimidinas como inhibidores de cinasas dependientes de ciclinas
ECSP077424A (es) Derivados de quinuclidina y su uso como antagonistas del receptor muscarínico m3
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
CL2011000880A1 (es) Compuestos derivados de pirazolo[1,5-a]pirimidin-3-il, inhibidores de tirosina de la familia trk cinasa; proceso para la preparacion de los compuestos; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de medicamentos utiles para el tratamiento del dolor y del cancer.
PE20070723A1 (es) Imidazopirazinas como inhibidores de quinasas dependientes de ciclina
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
ATE384061T1 (de) Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren
DOP2010000217A (es) Compuestos de 3h-[1,2,3] triazolo[4,5-d]pirimidina, su uso como inhibidores de mtor quinasa y p13 y sus sintesis
PE20130602A1 (es) Derivados de 6-cicloalquil-1,5-dihidro-pirazolo(3,4-d)pirimidin-4-onas y su uso como inhibidores de pde9a

Legal Events

Date Code Title Description
FC Refusal